期刊文献+

CEACAM6介导上皮间质转化增强胰腺癌细胞侵袭能力和耐药性的研究 被引量:3

CEACAM6 enhances the ability of invasion and chemo-resistance in pancreatic cancer cells by inducing epithelial-mesenchymal transition(EMT)
下载PDF
导出
摘要 目的:研究CEACAM6对胰腺癌细胞株SW1990侵袭能力和耐药性的影响,并探讨上皮间质转化(EMT)在其中的作用。方法:筛选及鉴定过表达CEACAM6的稳定转染SW1990-CEACAM6细胞株,通过定量PCR和Western blot方法检测SW1990细胞株中EMT相关表型标志物的改变。通过Transwell实验检测过表达CEACAM6对SW1990细胞株侵袭的影响,MTT法检测耐药指数(RI)。结果:定量PCR及Western blot验证过表达CEACAM6细胞株SW1990-CEACAM6成功建立,其倾向于向间质细胞转化:波形蛋白(Vimentin)表达明显上调,E-钙黏蛋白(E-cadherin)表达下降。功能实验证实过表达CEACAM6具有促进SW1990胰腺癌细胞株侵袭作用,同时细胞株耐药性增强。结论:CEACAM6能够促进SW1990胰腺癌细胞株上皮间质转化,从而促进胰腺癌细胞的恶性转化。 Objective:To investigate the potential involvement of CEACAM6 in the invasion and chemo-resistance of pancreatic cancer cell SW1990 by inducing epithelial-mesenchymal transition(EMT).Methods:After establishing and screening,CEACAM6overexpressing cell line SW1990-CEACAM6 was observed by inverted microscope,and the changes of EMT markers were determined by Q-PCR and western blot,the invasion ability was detected by transwell,the chemo-sensitivity to gemcitabine was determined by MTT assay.Results:Q-PCR and Western blot confirmed that SW1990-CEACAM6 cell line was established successfully.Overexpression of CEACAM6 made the pancreatic cell line SW1990 prone to mesenchymal phenotype,such as up-regulation of vimentin and down-regulation of E-cadherin.SW1990-CEACAM6 cell has greater activity of invasion and chemo-resistance to gemcitabine(P 0.05) than SW1990-EGFP cell.Conclusion:CEACAM6 could promote EMT and enhance malignant potential in terms of invasion and chemo-resistance in pancreatic cancer cell.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第12期1675-1679,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助(30972912)
关键词 SW1990胰腺癌细胞株 CEACAM6 上皮间质转化 侵袭 耐药 pancreatic cancer cell line SW1990 CEACAM6 epithelial-mesenchymal transition invasion chemo-resistance
  • 相关文献

参考文献1

二级参考文献16

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
  • 2Jemal A,Tiwari RC,Murray T,et al.Cancer statistics,2004[J].CA Cancer J Clin,2004,54(1):8-29.
  • 3Philip PA,Mooney M,Jaffe D,et al.Consensus report ofthe national cancer institute clinical trials planning meet-ing on pancreas cancer treatment[J].J Clin Oncol,2009,27(33):5660-5669.
  • 4Fryer RA,Galustian C,Dalgleish AG.Recent advancesand developments in treatment strategies against pancre-atic cancer[J].Curr Clin Pharmacol,2009,4(2):102-112.
  • 5Thiery JP,Acloque H,Huang RY,et al.Epithelial-mes-enchymal transitions in development and disease[J].Cell,2009,139(5):871-890.
  • 6Kalluri R,Weinberg RA.The basics of epithelial-mes-enchymal transition[J].J Clin Invest,2009,119(6):1420-1428.
  • 7Zeisberg M,Neilson EG.Biomarkers for epithelial-mes-enchymal transitions[J].J Clin Invest,2009,119(6):1429-1437.
  • 8Mani SA,Guo W,Liao MJ,et al.The epithelial-mesenchy-mal transition generates cells with properties of stem cells[J].Cell,2008,133(4):704-715.
  • 9Lee TK,Poon RT,Yuen AP,et al.Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition[J].Clin Cancer Res,2006,12(18):5369-5376.
  • 10Ke XS,Qu Y,Goldfinger N,et al.Epithelial to mesenchy-mal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transfor-mation[J].PLos One,2008,3(10):3368.

共引文献1

同被引文献75

  • 1中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2011版)[J].中国癌症杂志,2011,21(5):367-417. 被引量:269
  • 2贾长河,王文玉,任颖,张昊,兰玲,刘博伟,于静.重组人血管内皮抑制素注射液佐治晚期胃癌的疗效及对血清中血管内皮生长因子、S100A4和癌胚抗原相关细胞黏附分子的影响[J].中国老年学杂志,2014,34(1):208-209. 被引量:10
  • 3Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(1) :69-90.
  • 4Quirke P, Risio M, Lambert R, et al. Quality assurance in patholo- gy in colorectal cancer screening and diagnosis-European recom- mendations[J]. Virchows Arch,2011,458(1) : 1-19.
  • 5Gold P, Freedman SO. Specific cancinoembryonic antigens of the human digestive system[J]. J Exp Med,1965,122(4):467-481.
  • 6Shibaguchi H,Tsuru H,Kuroki M,et al. Enhancement of the an- titumor effect on combination therapy of an anticancer drug and its antibody against carcinoembryonic antigen[J]. Chemotherapy,2012,58(2):110-117.
  • 7Zhang D, Yu M, Xu T, et al. Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population [J ]. Hepatogastroenterol, 2013, 60 (126) : 1301-1309.
  • 8Ishihara S, Watanabe T, Kiyomatsu T, et al. Prognostic signifi- cance of response to preoperative radiotherapy, lymph node me- tastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer[J]. Int J Colorectal Dis, 2010,25 (11) : 1417-1425.
  • 9Lee JS, Park S, Park JM, et al. Elevated levels of serum tumor markers CA15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers[J]. Breast Cancer Res Treat, 2013,141 (3) :477-484.
  • 10Yang XQ,Chen C,Wang FB,et al. Preoperative serum carcinoem bryonic antigen,carbohydrate antigen19-9 and carbohydrate anti gen 125 as prognostic factors for recurrence-free survival in color ectalcancer[J]. Asian Pac J Cancer Prev, 2011,12(5): 1251 -1256.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部